Immunotherapy & Immuno-Oncology
Part of Healthcare - Oncology
| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
 JNJ | Johnson & Johnson | $0.5t | $228.06 | +0.6% | 3.0M |
 ABBV | ABBVIE INC. | $349.7b | $208.35 | -1.0% | 2.0M |
 AZN | AstraZeneca PLC | $289.5b | $184.04 | +1.4% | 686.2K |
 MRK | Merck & Co., Inc. | $271.8b | $112.17 | +0.7% | 2.7M |
 AMGN | Amgen Inc | $183.1b | $323.88 | -0.7% | 802.1K |
 BMY | Bristol-Myers Squibb Co. | $119.0b | $57.58 | +1.0% | 6.3M |
 REGN | Regeneron Pharmaceuticals Inc | $76.7b | $630.94 | -9.6% | 2.2M |
 RPRX | Royalty Pharma plc Class A Ordinary Shares | $22.0b | $52.43 | -0.8% | 1.7M |
 MRNA | Moderna, Inc. Common Stock | $18.7b | $48.31 | -1.5% | 2.7M |
 IBRX | ImmunityBio, Inc. Common Stock | $7.2b | $7.97 | +0.1% | 7.8M |
 ACLX | Arcellx, Inc. Common Stock | $6.7b | $115.06 | -0.0% | 16.1M |
 CGON | CG Oncology, Inc. Common stock | $5.8b | $63.80 | -4.7% | 416.1K |
 RCUS | Arcus Biosciences, Inc. | $3.1b | $23.77 | -0.0% | 625.0K |
 NKTR | Nektar Therapeutics | $2.8b | $67.21 | -4.8% | 654.2K |
 INBX | Inhibrx Biosciences, Inc. Common Stock | $1.9b | $105.72 | -2.7% | 186.9K |
 SNDX | Syndax Pharmaceuticals, Inc. | $1.9b | $19.55 | -3.3% | 670.0K |
 IMTX | Immatics N.V. Ordinary Shares | $1.6b | $10.53 | -3.1% | 218.7K |
 BCAX | Bicara Therapeutics Inc. Common Stock | $1.4b | $19.43 | -3.9% | 272.8K |
 PGEN | Precigen, Inc. Common Stock | $1.4b | $4.14 | -6.2% | 2.1M |
 IOVA | Iovance Biotherapeutics, Inc. Common Stock | $1.4b | $3.46 | +0.1% | 5.6M |
 CRVS | Corvus Pharmaceuticals, Inc. | $1.3b | $11.94 | -3.0% | 1.7M |
 OMER | Omeros Corporation | $1.1b | $12.07 | -1.4% | 1.0M |
 XNCR | Xencor, Inc. | $0.9b | $11.14 | -0.7% | 430.6K |
 SLS | SELLAS Life Sciences Group, Inc. Common Stock | $0.9b | $7.32 | +3.4% | 6.2M |
 CTMX | CytomX Therapeutics, Inc. | $0.9b | $3.48 | -3.5% | 1.6M |
 JANX | Janux Therapeutics, Inc. Common Stock | $0.9b | $13.79 | -0.7% | 291.2K |
 CGEM | Cullinan Therapeutics, Inc. Common Stock | $0.8b | $15.26 | -3.0% | 1.4M |
 CBIO | Crescent Biopharma, Inc. Common Stock | $0.7b | $18.12 | -9.3% | 270.3K |
 CADL | Candel Therapeutics, Inc. Common Stock | $454.1m | $8.08 | -7.9% | 3.0M |
 AURA | Aura Biosciences, Inc. Common Stock | $446.8m | $7.47 | -3.5% | 520.2K |
 CMPX | Compass Therapeutics, Inc. Common Stock | $331.4m | $1.82 | -1.9% | 2.7M |
 GLSI | Greenwich LifeSciences, Inc. | $315.9m | $27.20 | -0.0% | 61.5K |
 CHRS | Coherus Oncology, Inc. Common Stock | $265.3m | $1.50 | -4.8% | 1.1M |
 CGEN | Compugen Ltd | $258.1m | $2.85 | +3.8% | 1.2M |
 CNTX | Context Therapeutics Inc. Common Stock | $230.6m | $2.15 | -0.7% | 365.3K |
 ALXO | ALX Oncology Holdings Inc. Common Stock | $220.7m | $2.00 | -1.2% | 386.5K |
 REPL | Replimune Group, Inc. | $212.2m | $5.04 | -3.4% | 3.0M |
 ELTX | Elicio Therapeutics, Inc. Common Stock | $198.7m | $9.71 | -8.6% | 94.8K |
 MGNX | MacroGenics, Inc. | $191.3m | $4.22 | -0.6% | 818.9K |
 AGEN | Agenus Inc. | $149.4m | $3.21 | -10.2% | 490.7K |
 HURA | TuHURA Biosciences, Inc. Common Stock | $135.4m | $2.31 | 0.0% | 228.1K |
 GNLX | Genelux Corporation Common Stock | $113.4m | $2.88 | -1.2% | 109.8K |
 ONCY | Oncolytics Biotech, Inc. Common Shares | $104.6m | $0.80 | -5.7% | 818.2K |
 ANIX | Anixa Biosciences, Inc. | $100.9m | $2.77 | -1.6% | 84.6K |
 XBIT | XBiotech Inc | $77.4m | $2.42 | -1.6% | 28.5K |
 MAIA | MAIA Biotechnology, Inc. | $75.8m | $1.30 | +3.6% | 296.3K |
 IBO | Impact BioMedical, Inc. | $71.2m | $0.55 | +2.7% | 12.3K |
 BYSI | BeyondSpring Inc. Ordinary Shares | $62.1m | $1.38 | +1.1% | 19.8K |
 TIL | Instil Bio, Inc. Common Stock | $54.8m | $8.11 | +0.5% | 40.9K |
 PDSB | PDS Biotechnology Corporation Common Stock | $50.3m | $1.19 | -11.2% | 779.5K |